Veloxis
Europe, Hovedstaden, Denmark, Hørsholm
Description
Veloxis is a speciality pharmaceutical company focused on the development and commercialization of Envarsus.
Investor Profile
Veloxis has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Convertible Note rounds (top funding stages).
- Majority of deals are located in The Netherlands.
- Strong thematic focus on Biotechnology, Life Science, Therapeutics.
Stage Focus
- Convertible Note (100%)
Country Focus
- The Netherlands (100%)
Industry Focus
- Biotechnology
- Life Science
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Veloxis frequently co-invest with?
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
What are some of recent deals done by Veloxis?
Find More Investors Like Veloxis
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
